Importance_NN of_IN Testing_NP Stool_NP Specimens_NP for_IN Shiga_NP Toxins_NNS H7_JJ (_( ECO157_JJ )_) ,_, are_VBP well_RB established_VBN as_IN the_DT major_JJ cause_NN of_IN hemolytic_JJ uremic_JJ syndrome_NN (_( HUS_NP )_) and_CC hemorrhagic_JJ colitis_NN ._SENT According_VBG to_TO the_DT Centers_NPS for_IN Disease_NP Control_NP and_CC Prevention_NP (_( CDC_NP )_) ,_, at_IN least_JJS 200_CD deaths_NNS and_CC 20,000_CD illnesses_NNS in_IN the_DT United_NP States_NPS are_VBP annually_RB attributed_VBN to_TO ST-producing_NP E._NP coli_NNS (_( STEC_NP )_) organisms_NNS belonging_VBG to_TO the_DT O157:H7_JJ serotype_NN ._SENT However_RB ,_, it_PP is_VBZ indisputable_JJ that_IN serotypes_NNS other_JJ than_IN O157_JJ also_RB cause_VB clinical_JJ illness_NN identical_JJ to_TO that_DT of_IN STO157_JJ ,_, and_CC more_JJR than_IN 50_CD STECs_NNS are_VBP believed_VBN to_TO exist_VB ._SENT The_DT STECs_NP other_JJ than_IN O157_JJ (_( STNO157_JJ )_) are_VBP widely_RB prevalent_JJ outside_IN the_DT United_NP States_NP but_CC are_VBP believed_VBN to_TO be_VB at_IN very_RB low_JJ prevalence_NN in_IN this_DT country_NN ._SENT For_IN this_DT reason_NN ,_, the_DT majority_NN of_IN the_DT laboratories_NNS in_IN this_DT country_NN do_VBP not_RB search_VB for_IN STNO157_JJ ._SENT The_DT delayed_JJ advent_NN of_IN commercially_RB available_JJ assays_NNS for_IN ST_NP may_MD also_RB have_VB contributed_VBN to_TO a_DT lack_NN of_IN testing_NN for_IN STNO157_JJ ._SENT It_PP is_VBZ appropriate_JJ to_TO quote_VB Acheson_NP and_CC Keusch_NP in_IN this_DT regard_NN :_: "_`` We_PP cannot_MD let_VB ourselves_PP be_VB complacent_JJ in_IN thinking_VBG that_IN E._NP coli_NNS O157:H7_NP is_VBZ the_DT only_JJ Shiga-toxin_NP producing_NN microorganism_NN that_WDT can_MD cause_VB problems_NNS ._SENT "_'' At_IN Inova_NP Fairfax_NP Hospital_NP ,_, we_PP began_VBD to_TO test_VB for_IN ST_NN in_IN June_NP 1995_CD ._SENT The_DT purpose_NN of_IN this_DT paper_NN is_VBZ to_TO show_VB that_IN there_EX is_VBZ a_DT much_RB greater_JJR incidence_NN of_IN STNO157_NP than_IN was_VBD previously_RB suspected_VBN ._SENT All_DT stool_NN specimens_NNS submitted_VBN for_IN bacterial_JJ culture_NN were_VBD inoculated_VBN onto_IN sorbitol_NN MacConkey_NP agar_NN (_( SMAC_NP )_) in_IN addition_NN to_TO media_NNS for_IN isolation_NN of_IN the_DT usual_JJ enteric_JJ pathogens_NNS ._SENT The_DT ST_NP assays_NNS were_VBD performed_VBN only_RB on_IN specimens_NNS exhibiting_VBG one_CD of_IN the_DT following_VBG characteristics_NNS :_: liquid_JJ ,_, semiliquid_JJ ,_, mucous_JJ ,_, or_CC bloody_JJ ._SENT Additionally_RB ,_, specimens_NNS for_IN ST_JJ testing_NN were_VBD inoculated_VBN into_IN MacConkey_NP broth_NN and_CC incubated_VBD overnight_RB ._SENT Early_RB in_IN this_DT study_NN ,_, STO157_JJ was_VBD identified_VBN by_IN biochemical_JJ tests_NNS ,_, latex_NN agglutination_NN ,_, and_CC fluorescence_NN antibody_NN stain_NN ,_, but_CC the_DT ImmunoCard_NP STAT_NP E._NP coli_NNS O157:H7_JJ (_( Meridian_NP Diagnostics_NP ,_, Cincinnati_NP ,_, Ohio_NP )_) later_RBR replaced_VBN the_DT fluorescence_NN antibody_NN staining_VBG procedure_NN ._SENT The_DT ST_NP assay_NN was_VBD performed_VBN by_IN using_VBG the_DT Premier_NP EHEC_NP kit_NN (_( Meridian_NP Diagnostics_NP )_) following_VBG the_DT manufacturer_NN 's_POS instructions_NNS ._SENT The_DT test_NN kit_NN contains_VBZ microwell_NN test_NN strips_NNS coated_VBN with_IN monoclonal_NN anti-ST_NP I_NP and_CC II_NP ._SENT The_DT toxin_NN assay_NN was_VBD performed_VBN directly_RB from_IN fresh_JJ stools_NNS and_CC from_IN MacConkey_NP broth_NN cultures_NNS ._SENT Isolates_NNS of_IN STO157_JJ and_CC STNO157_JJ were_VBD submitted_VBN to_TO the_DT Commonwealth_NP of_IN Virginia_NP ,_, Division_NP of_IN Consolidated_NP Laboratory_NP Services_NPS (_( DCLS_NP )_) for_IN confirmation_NN of_IN STO157_JJ or_CC STNO157_JJ ._SENT The_DT STNO157_JJ isolates_NNS were_VBD referred_VBN to_TO CDC_NP by_IN DCLS_NP for_IN serotyping_NN ._SENT In_IN the_DT past_JJ six_CD and_CC a_DT half_JJ years_NNS ,_, the_DT following_VBG enteric_JJ pathogens_NNS (_( with_IN numbers_NNS of_IN cases_NNS in_IN parentheses_NNS )_) were_VBD isolated_VBN from_IN our_PP$ 660-bed_JJ community_NN tertiary_JJ care_NN hospital_NN :_: Salmonella_NN (_( 125_CD )_) ,_, STEC_NP (_( 65_CD )_) ,_, Shigella_NP (_( 58_CD )_) ,_, Campylobacter_NP (_( 46_CD )_) ,_, and_CC Vibrio_NP parahemolyticus_NNS (_( 4_CD )_) ._SENT All_DT of_IN the_DT STEC_NP isolates_NNS referred_VBD for_IN confirmation_NN were_VBD correctly_RB identified_VBN as_IN either_DT STO157_JJ or_CC STNO157_JJ ._SENT Among_IN the_DT 65_CD patients_NNS with_IN STEC_NP ,_, 45_CD had_VBD E._NP coli_NNS serotypes_NNS belonging_VBG to_TO STO157_JJ whereas_IN 20_CD (_( 31_CD %_NN )_) had_VBD isolates_NNS that_WDT were_VBD found_VBN to_TO be_VB STNO157_JJ with_IN the_DT following_VBG distribution_NN (_( serotypes_NNS in_IN parentheses_NNS )_) :_: 4_LS (_( O45:H2_NP )_) ,_, 3_CD (_( O26:H12_NP )_) ,_, 3_CD (_( O103:H2_NP )_) ,_, 3_CD (_( O111:NM_NP )_) ,_, 3_CD (_( O153:H2_NP )_) ,_, 2_CD (_( O88:H25_NP )_) ,_, 1_CD (_( O145:NM_NP )_) ,_, 1_CD (_( O96:H9_NP )_) ._SENT There_EX were_VBD four_CD HUS_NP cases_NNS (_( three_CD children_NNS and_CC one_CD adult_NN )_) with_IN no_DT fatality_NN ,_, and_CC all_DT were_VBD caused_VBN by_IN STO157_JJ ._SENT The_DT majority_NN of_IN STO157_JJ patients_NNS (_( 84_CD %_NN )_) exhibited_VBN bloody_JJ stools_NNS ,_, while_IN only_RB 45_CD %_NN of_IN STNO157_JJ patients_NNS produced_VBD bloody_JJ stools_NNS ._SENT The_DT SMAC_NP plates_NNS missed_VBD four_CD STO157_JJ specimens_NNS ,_, but_CC subculturing_VBG the_DT broth_NN enabled_VBD the_DT isolation_NN of_IN STO157_JJ ._SENT There_EX was_VBD only_RB one_CD specimen_NN from_IN which_WDT broth_NN culture_NN failed_VBD to_TO yield_VB a_DT positive_JJ ST_NN reaction_NN ;_: however_RB ,_, the_DT SMAC_NP showed_VBD a_DT few_JJ sorbitol-negative_JJ STO157_JJ colonies_NNS ._SENT The_DT ST_JJ assay_NN from_IN direct_JJ stools_NNS and_CC broth_NN cultures_NNS yielded_VBD 42_CD positives_NNS of_IN 65_CD samples_NNS (_( 65_CD %_NN )_) and_CC 64_CD positives_NNS of_IN 65_CD samples_NNS (_( 98_CD %_NN )_) ,_, respectively_RB ._SENT TABLE_NN 1_CD :_: Profiles_NNS of_IN patients_NNS and_CC Shiga_NP toxin-producing_JJ E._NP coli_NNS In_IN Europe_NP and_CC South_NP America_NP ,_, more_JJR than_IN 50_CD serotypes_NNS of_IN STNO157_JJ are_VBP known_VBN to_TO be_VB associated_VBN with_IN outbreaks_NNS of_IN HUS_NP and_CC hemorrhagic_JJ colitis_NN ._SENT In_IN a_DT Belgian_JJ study_NN involving_VBG 10,242_CD stool_NN samples_NNS ,_, the_DT isolation_NN rate_NN of_IN STEC_NP was_VBD 1_CD %_NN ,_, of_IN which_WDT 38_CD %_NN were_VBD ECO157_JJ and_CC 62_CD %_NN were_VBD STNO157_JJ ._SENT In_IN addition_NN ,_, STEC_NP was_VBD isolated_VBN from_IN 13_CD patients_NNS among_IN 468_CD gastroenteritis_NN cases_NNS in_IN a_DT German_JJ pediatric_JJ hospital_NN in_IN which_WDT 2_CD were_VBD identified_VBN as_IN ECO157_JJ and_CC 11_CD as_IN STNO157_JJ ,_, whereas_IN in_IN France_NP 6_CD of_IN 69_CD HUS_NP cases_NNS were_VBD caused_VBN by_IN STNO157_JJ ._SENT In_IN the_DT United_NP States_NPS ,_, the_DT publicity_NN of_IN STNO157_JJ cases_NNS has_VBZ been_VBN limited_VBN ,_, contributing_VBG to_TO an_DT underestimation_NN of_IN its_PP$ clinical_JJ importance_NN ._SENT Moreover_RB ,_, the_DT CDC_NP did_VBD not_RB underscore_VB its_PP$ importance_NN until_IN last_JJ year_NN at_IN the_DT 101st_NP Annual_NP Meeting_VBG of_IN the_DT American_NP Society_NP for_IN Microbiology_NP ._SENT In_IN 1994_CD the_DT U.S._NP Department_NP of_IN Agriculture_NP 's_POS Food_NP Safety_NP and_CC Inspection_NP Service_NP (_( FSIS_NP )_) introduced_VBD a_DT ground-beef_NN testing_NN program_NN for_IN E._NP coli_NNS O157:H7_JJ ._SENT Interestingly_RB ,_, in_IN January_NP 2002_CD ,_, the_DT American_NP Society_NP for_IN Microbiology_NP 's_POS Public_NP and_CC Scientific_NP Affairs_NPS Board_NP Committee_NP on_IN Agriculture_NP and_CC Food_NP Microbiology_NP submitted_VBD a_DT recommendation_NN to_TO FSIS_NP to_TO include_VB the_DT testing_NN for_IN STNO157_JJ ._SENT We_PP do_VBP not_RB know_VB the_DT incidence_NN of_IN STNO157_JJ in_IN this_DT country_NN due_JJ to_TO a_DT lack_NN of_IN consistent_JJ testing_NN ._SENT However_RB ,_, our_PP$ data_NNS from_IN northern_JJ Virginia_NP show_VBP that_IN 31_CD %_NN (_( 20_CD of_IN 65_CD )_) of_IN STECs_NP were_VBD attributed_VBN to_TO STNO157_JJ and_CC 45_CD %_NN (_( 9_CD of_IN 20_CD )_) of_IN those_DT patients_NNS produced_VBD bloody_JJ diarrhea_NN ._SENT Without_IN the_DT ST_JJ assay_NN ,_, the_DT diagnoses_NNS of_IN 25_CD patients_NNS (_( 5_CD with_IN STO157_JJ and_CC 20_CD with_IN STNO157_JJ )_) would_MD have_VB been_VBN missed_VBN ._SENT TABLE_NN 2_CD |_SYM Annual_JJ incidence_NN of_IN Shiga_NP toxin-producing_JJ E._NP coli_NNS In_IN our_PP$ institution_NN ,_, physicians_NNS are_VBP immediately_RB notified_VBN once_IN ST_NP is_VBZ detected_VBN (_( 3_CD to_TO 30_CD h_NN )_) directly_RB from_IN stools_NNS or_CC broth_NN cultures_NNS ._SENT In_IN such_JJ cases_NNS ,_, patients_NNS are_VBP often_RB discharged_VBN in_IN 1_CD to_TO 2_CD days_NNS without_IN antibiotic_JJ treatment_NN or_CC invasive_JJ procedures_NNS unless_IN complications_NNS such_JJ as_IN HUS_NP and_CC dehydration_NN occur_VBP ._SENT In_IN 1997_CD ,_, a_DT liver_NN transplant_NN patient_NN presented_VBN with_IN a_DT severe_JJ hemorrhagic_JJ colitis_NN in_IN the_DT late_JJ evening_NN ._SENT The_DT direct_JJ stool_NN ST_NN assay_NN performed_VBD the_DT next_JJ morning_NN due_JJ to_TO the_DT bloody_JJ appearance_NN of_IN the_DT stool_NN was_VBD strongly_RB positive_JJ ,_, establishing_VBG the_DT etiology_NN in_IN 10_CD h._NNS This_DT isolate_NN was_VBD identified_VBN as_IN STNO157_NP and_CC was_VBD later_RBR confirmed_VBN as_IN O26:H11_NP ._SENT Our_PP$ rapid_JJ diagnosis_NN prevented_VBN further_RBR exploratory_JJ procedures_NNS and_CC longer_JJR hospitalization_NN ._SENT Not_RB every_DT laboratory_NN has_VBZ sufficient_JJ resources_NNS to_TO incorporate_VB ST_JJ assays_NNS in_IN addition_NN to_TO the_DT use_NN of_IN SMAC_NP plates_NNS ._SENT However_RB ,_, an_DT attempt_NN should_MD at_IN least_JJS be_VB made_VBN to_TO test_VB for_IN ST_NP when_WRB bloody_JJ stools_NNS or_CC suspected_JJ cases_NNS do_VBP not_RB result_VB in_IN the_DT isolation_NN of_IN O157:H7_JJ on_IN SMAC_NP ._SENT Since_IN STNO157_JJ serotypes_NNS are_VBP sorbitol_NN fermenters_NNS and_CC have_VBP no_DT unique_JJ phenotypic_JJ markers_NNS ,_, the_DT toxin_NN assay_NN is_VBZ the_DT only_JJ method_NN of_IN detection_NN available_JJ to_TO clinical_JJ laboratories_NNS ._SENT Another_DT reason_NN for_IN which_WDT we_PP are_VBP advocating_VBG the_DT use_NN of_IN toxin_NN in_IN addition_NN to_TO the_DT use_NN of_IN SMAC_NP is_VBZ the_DT relatively_RB low_JJ sensitivity_NN of_IN SMAC_NP for_IN the_DT detection_NN of_IN STO157_JJ ._SENT Visible_JJ sorbitol-negative_JJ colonies_NNS do_VBP not_RB always_RB prevail_VB over_IN the_DT sorbitol-positive_JJ enteric_JJ flora_NN ._SENT The_DT presence_NN of_IN only_RB a_DT few_JJ colonies_NNS is_VBZ often_RB obscured_VBN by_IN the_DT overwhelming_JJ number_NN of_IN sorbitol_NN fermenters_NNS ._SENT During_IN this_DT study_NN ,_, 5_CD of_IN 45_CD (_( 11_CD %_NN )_) specimens_NNS did_VBD not_RB exhibit_VB sorbitol-negative_JJ colonies_NNS on_IN SMAC_NP ,_, but_CC the_DT isolation_NN of_IN STO157_JJ colonies_NNS was_VBD possible_JJ by_IN subculturing_VBG the_DT ST-positive_JJ broth_NN ._SENT The_DT sensitivity_NN of_IN SMAC_NP plating_NN reported_VBD by_IN investigators_NNS ranges_NNS from_IN 50_CD to_TO 82.5_CD %_NN ._SENT Since_IN most_JJS laboratories_NNS are_VBP using_VBG only_RB SMAC_JJ as_IN the_DT primary_JJ plate_NN medium_NN ,_, one_PP would_MD not_RB recognize_VB its_PP$ limitation_NN unless_IN another_DT method_NN ,_, such_JJ as_IN the_DT toxin_NN assay_NN or_CC PCR_NP ,_, is_VBZ employed_VBN concomitantly_RB ._SENT Generally_RB ,_, the_DT use_NN of_IN SMAC_NP is_VBZ perceived_VBN as_IN the_DT "_`` gold_JJ standard_NN "_'' for_IN the_DT isolation_NN of_IN STO157_JJ ,_, although_IN our_PP$ results_NNS as_RB well_RB as_IN other_JJ findings_NNS demonstrate_VBP otherwise_RB ._SENT The_DT existence_NN and_CC prevalence_NN of_IN the_DT sorbitol-positive_JJ STEC_NP have_VBP not_RB been_VBN identified_VBN in_IN this_DT country_NN ,_, for_IN no_DT one_CD has_VBZ actively_RB searched_VBN for_IN it_PP ._SENT In_IN the_DT Czech_NP Republic_NP ,_, however_RB ,_, there_EX were_VBD two_CD cases_NNS of_IN HUS_NP caused_VBD by_IN sorbitol-positive_JJ O157:H7_JJ ,_, and_CC this_DT strain_NN is_VBZ also_RB believed_VBN to_TO be_VB widespread_JJ in_IN Germany_NP ,_, with_IN cattle_NNS being_VBG a_DT possible_JJ reservoir_NN ._SENT Again_RB ,_, the_DT toxin_NN assay_NN is_VBZ currently_RB the_DT only_JJ method_NN of_IN detecting_VBG such_JJ strains_NNS due_JJ to_TO the_DT lack_NN of_IN phenotypic_JJ markers_NNS ._SENT In_IN conclusion_NN ,_, our_PP$ data_NNS clearly_RB demonstrate_VBP that_IN STNO157_NP is_VBZ more_RBR prevalent_JJ than_IN we_PP were_VBD aware_JJ of_IN ,_, leading_VBG us_PP to_TO believe_VB that_IN the_DT use_NN of_IN SMAC_NP alone_RB for_IN detection_NN may_MD be_VB insufficient_JJ ._SENT 